NIH awards $3.1 million grant for Washington University, St. Jude ALS research
Rohit Pappu and collaborator Tanja Mittag received $3.1 to study RNA-binding proteins that are mutated in patients with familial forms of ALS
Clinical trial in children to investigate rare inflammatory disorder linked to COVID-19
Washington University pediatricians who treat patients at St. Louis Children’s Hospital are part of a major research effort to investigate how the novel coronavirus affects children and young adults, including its role in a rare but serious inflammatory syndrome.
Brainscapes
The Warped, Wondrous Maps Written in Your Brain—And How They Guide You
A path-breaking journey into the brain, showing how perception, thought, and action are products of “maps” etched into your gray matter—and how technology can use them to read your mind. Your brain is a collection of maps. That is no metaphor: scrawled across your brain’s surfaces are actual maps of the sights, sounds, and actions […]
Bowman receives grant to study Alzheimer’s disease
Gregory Bowman, associate professor of biochemistry and molecular biophysics at the School of Medicine, received a three-year $1,763,634 grant award from the National Institute on Aging of the National Institutes of Health (NIH) for his research titled “Structural basis for ApoE4-induced Alzheimer’s disease.”
Walking pace among cancer survivors may be important for survival
A new study from Washington University School of Medicine in St. Louis and the National Cancer Institute finds a possible link between slow walking pace and an increased risk of death among cancer survivors.
New evidence COVID-19 antibodies, vaccines less effective against variants
School of Medicine researchers have found that new variants of the virus that causes COVID-19 can evade antibodies that work against the original form of the virus, potentially undermining the effectiveness of vaccines and antibody-based drugs being used to prevent or treat COVID-19.
Opioid overdose reduced in patients taking buprenorphine
The drug buprenorphine is an effective treatment for opioid use disorder, but many who misuse opioids also take benzodiazepines to treat anxiety and similar conditions. School of Medicine researchers found that buprenorphine lowered the overdose risk, even in people who also took benzodiazepines such as Valium or Xanax.
COVID-19 can kill heart muscle cells, interfere with contraction
A study from Washington University School of Medicine in St. Louis provides evidence that the coronavirus that causes COVID-19 can invade and replicate inside heart muscle cells, causing cell death and interfering with heart muscle contraction.
Brown School working with St. Louis city on virus containment
New research from faculty at the Brown School at Washington University in St. Louis is providing guidance to local policymakers on how they might contain the spread of the virus that causes COVID-19 until vaccination ramps up to levels high enough to provide widespread protection.
Electrical signaling in cells focus of $8.8 million grant
Researchers at Washington University School of Medicine have received an eight-year, $8.8 million grant to study ion channels as potential targets for new drugs to treat disorders affecting the brain, heart and muscles.
Older Stories